Esposito Giuseppe, Imitola Jaime, Lu Jie, De Filippis Daniele, Scuderi Caterina, Ganesh Vijay S, Folkerth Rebecca, Hecht Jonathan, Shin Soojung, Iuvone Teresa, Chesnut Jonathan, Steardo Luca, Sheen Volney
Department of Human Physiology and Pharmacology, Vittorio Erspamer Faculty of Pharmacy, University of Rome La Sapienza, Rome, Italy.
Hum Mol Genet. 2008 Feb 1;17(3):440-57. doi: 10.1093/hmg/ddm322. Epub 2007 Nov 5.
Down syndrome (DS) is caused by trisomy of chromosome 21 and is characterized by mental retardation, seizures and premature Alzheimer's disease. To examine neuropathological mechanisms giving rise to this disorder, we generated multiple human DS neural progenitor cell (NPC) lines from the 19-21 week frontal cortex and characterized their genomic and functional properties. Microarray profiling of DS progenitors indicated that increased levels of gene expression were not limited to chromosome 21, suggesting that increased expression of genes on chromosome 21 altered transcriptional regulation of a subset of genes throughout the entire genome. Moreover, many transcriptionally dysregulated genes were involved in cell death and oxidative stress. Network analyses suggested that upregulated expression of chromosome 21 genes such as S100B and amyloid precursor protein activated the stress response kinase pathways, and furthermore, could be linked to upregulation of the water channel aquaporin 4 (AQP4). We further demonstrate in DS NPCs that S100B is constitutively overexpressed, that overexpression leads to increased reactive oxygen species (ROS) formation and activation of stress response kinases, and that activation of this pathway results in compensatory AQP4 expression. In addition, AQP4 expression could be induced by direct exposure to ROS, and siRNA inhibition of AQP4 resulted in elevated levels of ROS following S100B exposure. Finally, elevated levels of S100B-induced ROS and loss of AQP4 expression led to increased programmed cell death. These findings suggest that dysregulation of chromosome 21 genes in DS neural progenitors leads to increased ROS and thereby alters transcriptional regulation of cytoprotective, non-chromosome 21 genes in response to ongoing cellular insults.
唐氏综合征(DS)由21号染色体三体性引起,其特征为智力迟钝、癫痫发作和早发性阿尔茨海默病。为了研究导致这种疾病的神经病理机制,我们从19 - 21周龄的额叶皮质中生成了多个唐氏综合征人类神经祖细胞(NPC)系,并对其基因组和功能特性进行了表征。对唐氏综合征祖细胞的微阵列分析表明,基因表达水平的升高并不局限于21号染色体,这表明21号染色体上基因表达的增加改变了整个基因组中一部分基因的转录调控。此外,许多转录失调的基因与细胞死亡和氧化应激有关。网络分析表明,21号染色体上的基因如S100B和淀粉样前体蛋白的上调表达激活了应激反应激酶途径,而且可能与水通道水通道蛋白4(AQP4)的上调有关。我们进一步在唐氏综合征NPC中证明,S100B持续过表达,过表达导致活性氧(ROS)形成增加和应激反应激酶激活,并且该途径的激活导致AQP4的代偿性表达。此外,直接暴露于ROS可诱导AQP4表达,而对AQP4进行小干扰RNA(siRNA)抑制会导致在暴露于S100B后ROS水平升高。最后,S100B诱导的ROS水平升高和AQP4表达缺失导致程序性细胞死亡增加。这些发现表明,唐氏综合征神经祖细胞中21号染色体基因的失调导致ROS增加,从而改变了细胞保护相关的非21号染色体基因的转录调控,以应对持续的细胞损伤。